PuSH - Publication Server of Helmholtz Zentrum München

69 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Bölükbas, D.A. et al.: Fine-tuning lung cancer nanotherapy using closed cardiopulmonary circulation. In: (Trans. Annu. Meet. Soc. Biomater. Annu. Int. Biomater. Symp., 03-06 April 2019, Seattle, USA). 2019. 560 ( ; 40)
2.
Heitmeier, T.* et al.: Altered proteasome function in right ventricular hypertrophy. Cardiovasc. Res., accepted (2019)
3.
Kammerl, I.E. et al.: Dissecting the molecular effects of cigarette smoke on proteasome function. J. Proteomics 193, 1-9 (2019)
4.
Houssaini, A. et al.: mTOR pathway activation drives lung cell senescence and emphysema. JCI insight 3:93203 (2018)
5.
Meiners, S. ; Evankovich, J.* & Mallampalli, R.K.*: The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis. Transl. Res., accepted (2018)
6.
Meiners, S. ; Lloyd, C.* & Chambers, R.C.*: Cell–matrix interactions in lung disease and regeneration: ERS lung science conference 2018 report. Eur. Respir. Rev. 27:180040 (2018)
7.
Welk, V. et al.: Analyzing the role of proteasome activator 200 (PA200) in lung cancer. Eur. Respir. J. 52 (2018)
8.
Gromann, L.B.* et al.: First experiences with in-vivo x-ray dark-field imaging of lung cancer in mice. Proc. SPIE 10132:101325L (2017)
9.
Houssaini, A.* et al.: Activation of the Mtor pathway drives lung cell senescence and emphysema in chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 195 (2017)
10.
Kammerl, I.E. et al.: Deficiency of immunoproteasome subunits increases alternative polarization of alveolar macrophages. Am. J. Respir. Crit. Care Med. 195 (2017)
11.
Mossina, A. et al.: Cigarette smoke alters the secretome of lung epithelial cells. Proteomics 17:1600243 (2017)
12.
Scherer, K.* et al.: X-ray dark-field radiography - in-vivo diagnosis of lung cancer in mice. Sci. Rep. 7:402 (2017)
13.
Taggart, C.* et al.: Protean proteases: At the cutting edge of lung diseases. Eur. Respir. J. 49:1501200 (2017)
14.
Welk, V. et al.: Proteasomal activator 200 (pa200) regulates cellular proliferation: A putative role for Ipf and lung cancer pathogenesis. Am. J. Respir. Crit. Care Med. 195 (2017)
15.
Αgalioti, T.* et al.: Mutant KRAS promotes malignant pleural effusion formation. Nat. Commun. 8:15205 (2017)
16.
Chen, S. et al.: Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages. Cell Death Differ. 23, 1026-1037 (2016)
17.
Conlon, T.M. et al.: Metabolomics screening identifies reduced L-carnitine to be associated with progressive emphysema. Clin. Sci. 130, 273-287 (2016)
18.
Houssaini, A. et al.: Targeting the mtor signaling pathway to inhibit lung cell senescence in Chronic Obstructive Pulmonary Disease (COPD). Acta Physiol. 217, 142-143 (2016)
19.
Houssaini, A.* et al.: Targeting the mtor signaling pathway to inhibit lung cell senescence In chronic obstructive pulmonary disease (COPD). Am. J. Respir. Crit. Care Med. 193:A2330 (2016)
20.
Kammerl, I.E. et al.: Impairment of immunoproteasome function by cigarette smoke and in COPD. Am. J. Respir. Crit. Care Med. 193, 1230-1241 (2016)